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Summary 
Ligation of CD28 on CD4 Thl clones and freshly isolated mixtures of naive and memory CD4 
T  cells triggered their T  cell receptors (TCR) is su~cient  to induce the costimulatory signals 
necessary for interleukin 2 (IL-2) production by these cells. CTLA-4-reactive ligands expressed 
on antigen-presenting  cells (APC) are critical in providing costimulatory signals  to these T  cell 
populations. We demonstrate that these activation characteristics apply equally to purified naive 
CD4 T cells. Because B cell blasts express CTLA-4-reactive ligands and high levels of adhesion 
and major histocompatibility complex class II molecules, they would be expected to engage both 
the TCR and CD28 and consequently stimulate IL-2 production by naive CD4 T  cells.  Using 
purified populations of cells in limiting dilution cultures, we have carried out a quantitative analysis 
of the interaction between naive CD4 T cells and either activated B or dendritic cells. We demonstrate 
that  B cell blasts stimulate a high frequency of naive CD4 T  cells.  Slight differences in TCR 
signaling  ef~ciency between  the  two  APC  types  were  observed.  Even  at  optimal  peptide 
concentrations,  however, the amount of IL-2 made by individual T  cells was fourfold lower in 
response to B cell blasts than to dendritic cells. This relative deficiency of activated B cells was 
due to their  inability to  optimally costimulate naive CD4  T  cells. 
T 
he principal aim of this work was to examine the ability 
of various APC types to stimulate IL-2 secretion by naive 
CD4 T cells, with particular focus on activated B cells. Acti- 
vated B cells can clearly stimulate many T  cell hybridomas 
and clones, and freshly isolated populations of CD4 T  cells 
from unprimed animals,  which typically include both naive 
and memory T cells (1-3). In contrast, the question of whether 
activated B cells stimulate naive CD4 T  cells remains con- 
troversial.  Antigen-specific B cells are remarkably ef~cient at 
concentrating  and  processing  antigen  (4).  Moreover,  the 
specificity of B cells can influence the array of peptides gener- 
ated during  antigen processing (5-7).  These characteristics 
have been suggested to allow B cells to increase  the reper- 
toire of T  cell specificities  observed during  an immune  re- 
sponse, a phenomenon called diversification or determinant 
spreading  (8, 9).  A potential consequence of this is that  as 
B cells become activated during an immune response, B cells 
specific for an epitope shared between foreign and self an- 
tigen could process the self protein and present novel T cell 
determinants that have not been involved in intrathymic nega- 
tive selection. Were activated B cells able to stimulate naive 
T cells,  this would pose the risk of autoimmunity (10).  To 
counter this, it has been proposed that primed B cells tolerize 
naive T  cells.  Were activated B cells tolerogenic,  this could 
render peptide-carrier conjugates ineffective as T cell vaccines 
for individuals who already have carrier-primed B cells (11). 
Thus, the issue of whether activated B cells are stimulatory 
or tolerogenic for naive T cells is of both theoretical and prac- 
tical concern. 
Previous studies (12-17) have demonstrated  a role for B 
cells in primary T  cell responses in vivo.  It is not clear  in 
most of these studies, however, whether B cells directly present 
antigen to T cells or whether their involvement depends only 
on their production of antibody. Activated B cells have also 
been reported to stimulate naive T cells in vitro (18, 19). Be- 
cause of the questionable reliability of the CD45RB isoform 
as a marker for naive T  cells (20) and the large numbers of 
T  cells  and APCs used in  this  studies,  it is difficult to be 
certain that the observed responses were due to interactions 
between naive T  cells and activated B cells and not to con- 
taminating memory T  cells or non-B APCs.  In contrast to 
these studies, there are two recent reports that  activated B 
cells fail to prime (21) and instead tolerize naive T cells (22). 
The T  cell populations  directly examined in these studies, 
however, did not include peripheral  CD4 T  cells  and may 
reflect distinct activation requirements of other T cell subsets. 
Thus, the issue of activated B cells as APCs for naive CD4 
T cells remains unresolved and prompted the current study. 
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Animals.  B10.A and CBA/J mice were purchased from Charles 
River Laboratories (Wilmington, MA) through a contract with 
the National Cancer Institute, National Institutes of Health (NCI 
NIH,  Frederick,  MD)  and  used between  2  and  6  mo  of age. 
H-2  ~/b, pigeon cytochrome c (pcc)Lspecific and TCR-ce/3, trans- 
genic mice were derived by mating a (C57BL/6  x  SJL)F1 trans- 
genic mouse (provided by Dr. S. Hedrick, University of California 
at San Diego, La Jolla, CA) to B10.A mice, then backcrossing trans- 
genic mice with normal B10.A or C57BL/10 animals.  Mice be- 
tween the fifth and ninth backcross to the C57BL/10 background 
were used at 8-12 wk of age. These animals were housed in a bar- 
tier colony after embryo transfer at the fifth backcross generation. 
For priming, normal B10.A mice were injected subcutaneously with 
10 nmoles of the COOH-terminal fragment 81-104 of pcc (Sigma 
Chemical Co., St. Louis, MO) emulsified in CFA (Difco Laborato- 
ties, Detroit, MI). 
Culture Media and Reagents.  Lymphoid suspensions were made 
in a standard balanced salt solution containing 5% FCS (Biofluids, 
Inc., Rockville, MD) and 100 #g/ml DNase (Sigma Chemical Co.). 
Cell culture was carried out at 37~  5% CO2 in Eagle's Hanks' 
amino acid medium supplemented with 10% FCS,  2 mM gluta- 
mine, 100 U/ml penicillin, 100 U/ml streptomycin, 25/~g/ml gen- 
tamicin  (BioWhittaker  Inc.,  Walkersville,  MD),  50  /~M  2-ME 
(Sigma Chemical Co.), and an additional 1 mM sodium pyruvate, 
and 1X nonessential amino acids (Biofluids, Inc.). Mouse rib2 and 
GM-CSF  were purchased from Pharmingen  (San  Diego,  CA). 
Mouse rlL-4 was kindly provided by Dr. W. Paul (NIH, Bethesda, 
MD). Purified J11d.2 (cr heat stable antigen [HSA]) (Pharmingen) 
and ammonium sulfate (Mallinckrodt Specialty Chemicals Co., Paris, 
KY)-concentrated supernatants of the following mAb-producing 
hybridomas were used for cell depletions: 3-1.5.5  (aCD8), Jlj.10 
(c~Thy-l.2),  10-2.16 (cd-Ak), Y-17 (c~I-Ek), 33D1 (antispleen  den- 
dritic cells) (American Type Culture Collection, Rockville, MD), 
LICR..LAU.-tLL172.4  (aCD4),  and  SW3A4  (c~NKI.1,  kindly 
provided by Dr. V. Kumar, University of Texas Southwestern Medical 
Center, Dallas, TX). Expression of class II and adhesion molecules 
was determined by staining with FITC-conjugated mAb to I-E, 
intercellular  adhesion  molecule 1 (ICAM-1),  and  LFA-1 (Phar- 
mingen). CTLA4Ig refers to a fusion protein consisting of the ex- 
tracellular portion of either mouse or human CTLA-4 spliced onto 
the CH2  and CH3  domains of human  IgG1.  mCTLA4Ig and 
hCTLA4Ig, generously provided by Dr. P. Linsley (Bristol-Myers 
Squibb Pharmaceutical Research Institute, Seattle, WA), were used 
in this study with identical results. 37.51 hybridoma cells secreting 
c~CD28 mAb were the kind gift of Dr. J. Allison (University of 
California,  Berkeley,  CA).  GL1  (cgB7-2) mAb  was  generously 
provided by K. Hathcock and Dr.  R.  Hodes (NIH). 
Isolation ofCD4 Lymphocytes.  Nylon wool (Robbins Scientific 
Corp., Sunnyvale,  CA) nonadherent lymphoid suspensions  were 
incubated with 3-1.5.5, 10-2.16, Y-17, Jlld.2, SW3A4, DNase, and 
Low-Tox-M rabbit C' (Cedarlane Laboratories Limited, Hornby, 
Ontario, Canada) and centrifuged over Lymphocyte-M (Cedarlane). 
Viable cells were stained with allophycocyanin-GK1.5 (c~CD4), PE- 
IM7.8.1 (o~CD44), and FITC-RR4-7 (t~Va6) or RIL8-1 (c~V~11) 
(Pharmingen) and sorted on the FACStar  PLUS  |  (Becton Dick- 
inson & Co., Mountain View, CA). Sorted cells were in some ex- 
periments dispensed at one cell per well using a FACStar |  equipped 
with a FACS  |  Automated Cell Deposition Unit (ACDU) (Becton 
Dickinson & Co.,  Mountain View,  CA). 
1 Abbreviations used in this  paper: ICAM-1, intercellular adhesion molecule 
1; LDA, limiting dilution analysis; pcc, pigeon cytochrome c. 
Isolation ofSflenic B Cells.  Sephadex G10 (Pharmacia LKB, Upp- 
sala Sweden) nonadherent spleen cells were incubated with 3-1.5.5, 
RL172.4, Jlj.10, SW3A4, DNase, and guinea pig C' (GIBCO BRL 
Gaithersburg, MD). Viable cells were collected over Lympholyte- 
M.  For activation, calls were cultured in upright  25 cm  2 flasks 
(model 3050 Costar,  Cambridge, MA) for 24-60 h at 5  x  106/ml 
with 10 #g/m1 LPS B Escherichia coli 055:B5 (Difco Laboratories) 
or with 100/~g/ml poly I-poly C (Calbiochem-Novabiochem Corp., 
La Jolla, CA) in the absence or presence of 50 U/ml rIL-4. Purity 
of the resultant populations was determined by staining with FITC- 
or PE-B220 (o~CD45R)  (Pharmingen). 
Isolation of Splenic Dendritic Cells.  Splenic suspensions were in- 
cubated for 2 h in 5% CO2 at 37~  on Falcon 3025 tissue cul- 
ture plates (Becton Dickinson & Co., Cockeysville, MD). Nonad- 
herent cells were removed and plates were incubated for another 
6-24 h. Viable cells that had detached were collected after centrifu- 
gation over Lympholyte-M. Low density cells were further enriched 
by centrifugation over 50% Percoll (Pharmacia  LKB, Piscataway, 
NJ). Purity of the resultant population was determined by staining 
with biotinylated 33D1 mAb followed by PE-streptavidin  (Caltag 
Laborabories,  South San Francisco,  CA). 
Limiting Dilution Analysis (LDA) of lb2 Producers and APC.  To 
determine Ib2 producer frequencies, CD4 T cells were titrated into 
96-well round bottom plates (model 3799, Costar) with 20 repli- 
cate wells per cell density in the presence of excess peptide and APCs 
in a final volume of 50 #1. The APC frequency was determined 
by titrating APCs into wells containing nonlimiting numbers of 
CD4 T cells (i.e., 30-50). At least 72 h later, the plates were frozen, 
thawed,  and supplemented  with 103 CTL-L ceUs/well. After 16-24 
h, the wells were pulsed with I/zCi [3H]thymidine (6.7 Ci/mmol; 
ICN Radiochemicals,  Irvine, CA) and harvested 8-16 h later using 
a Brandell  Cell Harvester (Medical  Research and Development, 
Gaithersburg, MD). Proliferation of CTL-L, measured as isotope 
incorporation into DNA, was quantified with an LKB Betaplate 
scintillation  counter (Wallac,  Gaithersburg,  MD).  Background 
counts were determined in wells lacking CD4 cells, peptide, or 
APCs. Although CTL-L cells also proliferate in response to high 
concentrations of IL-4, the addition of alL-4 mAb had no effect, 
whereas the addition of alL-2 mAb prevented CTL-L growth, in- 
dicating that the only lymphokine measured in these cultures was 
IL-2. Ib2 concentrations in individual wells were determined by 
comparing CTL-L growth in these wells with growth in wells con- 
taining known quantities of rlL-2. The standard curve was fit to 
a logit function using a Marquand nonlinear regression algorithm. 
Wells were considered positive if the counts exceeded the mean 
background cpm by 3 SD. Statistical  analyses were done on the 
logarithms of the IL-2 units as these data were more normally dis- 
tributed than the counts per minute. Hence, the results  are ex- 
pressed as geometric means  x/+  the standard error of these means. 
Occasional wells with values exceeding the maximum of the stan- 
dard curve were excluded from the statistical  analysis. Frequencies 
were determined by the X  2 minimization method described  by 
Taswell (23). 
Results 
CD4  T  Cells Expressing  Low Levels of CD44  as a Source 
of Naive T  Cells.  Our first task was to identify and isolate 
naive T  cells. In immunized animals,  CD44 is expressed at 
higher levels on primed T  cells, which give detectable recall 
responses upon restimulation in vitro, than on naive T cells, 
which do not respond (24, 25). B10.A mice were immunized 
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of up to 3 too. Lymph node and spleen cells were sorted for 
the expression  of CD4 or additionally for the expression  of 
Vot11 and various levels of CD44,  the gates  of which are 
shown in the inset to Fig. 1. IL-2-producing ceUs were detected 
among CD4 T cells taken from primed animals. Frequencies 
of 1/20 to  1/40 were observed  with Vot11 + CD44hig  h re- 
sponders. In contrast,  Vot11  + cells expressing low or medium 
levels of CD44  contributed very little to  the response.  It 
should be noted that the frequency of responding cells was 
similar for unseparated CD4 T  cells and for those further 
enriched in Vot11+, CD44  m~t cells. Since CD4 T cells bearing 
Vot11-containing TCRs account for most of the response to 
the 81-104 fragment in B10.A mice (26) and represent 5% 
of the CD4 population (data not shown), we would have 
expected  at  least  a  20-fold  higher  frequency among  the 
CD44 l~  or CD44 reed subsets if they were involved in the re- 
sponse. Therefore, the low frequencies observed in these subsets 
reflect either a small role for such cells in memory responses 
or a small contamination with CD44~g  h CD4 T cells. Similar 
results were observed in three independent experiments. Thus, 
most memory cells maintain high CD44 expression for long 
periods and would therefore be excluded from populations 
of naive cells selected by their CD4# ~  phenotype in young 
adult mice. 
CD28  Ligation  Costimulates  IL-2  Production  by  Naive 
CD4 + T  Cells.  Memory CD4 Thl clones fail to proliferate 
or produce IL-2 when triggered through their TCRs in the 
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Figure  1.  Memory  of CD4 T cells  maintain  high expression  of CD44. 
(Inset) CD44 profile of Vcdl + CD4 T cells from primed B10.A mice. 
Lymph node and spleen CD4 T cells (O) from mice primed 5 (,4) or 
12 (B) wk earlier with pcc 81-104 in CFA were further  fractionated  into 
V~11 + cells expressing low ([Z), medium (A), or high (O) levels of 
CD44 using the sort gates indicated  in the inset. The cells were titrated 
into wells containing 105 irradiated (2,000 rad) T-depleted  B10.A spleen 
cells in the presence of 30 #M 81-104. The IL-2 producer (responder) fre- 
quencies and 95% confidence  intervals, calculated  by X  z minimization, 
were: (A) 1/4,400 (3,300-5,300) (O),  1/10,300 (6,600-14,500) ([q), 
1/6,300 (4,700-7,700) (A),  and 1/41 (29-51) (O); and (B)  1/1,700 
(1,300-2,000 (O), 1/2,400 (1,800-3,000) (i-q), 1/1,600 (1,200-1,800) (A), 
and 1/16 (12-20) (O). No responses were detected  with unprimed  cells 
in the presence of peptide or with primed cells in the absence of peptide 
(data not shown). 
absence of costimulatory signals (27). Ligation of the CD28 
molecule on the T cell suffices to costimulate IL-2 produc- 
tion and clonal expansion (28-30).  To determine whether 
CD28 ligation could similarly costimulate naive T cells, we 
used CD4 T  cells from animals transgenic for a TCR that 
recognizes  the  pcc  81-104  peptide  presented  by  I-E  k.  In 
transgenic mice of the appropriate MHC background, most 
of the peripheral T cells express the Vot11 transgene and CD4 
(31)  as  well  as  low  or  medium  levels of CD44;  most 
CD44 high CD4  T  cells  do  not  express  high levels of the 
Votll transgene (data not shown). To engage the TCR under 
noncostimulatory conditions, paraformaldehyde-fixed  I-E  k+ 
spleen cells were used to present the 81-104 peptide (27). Pe- 
ripheral Vot11 + CD44  l~  CD4 T cells produced IL-2 in re- 
sponse to peptide presented by irradiated splenic APCs as seen 
in  Table  1,  Expt.  I.  Occasionally,  the  frequency of IL-2 
producers was as high as 1/1. More typically the frequency 
was 1/2 to 1/5. In contrast, fixed spleen cells were unable 
to stimulate the CD4 T cells (frequency <1/20). IL-2 produc- 
tion could be restored, however, by the addition of otCD28 
mAb. Similar results were observed in each of seven experi- 
ments. These data indicate that peptide-pulsed, fixed APCs 
are capable of triggering the TCR and that ligation of CD28 
on naive CD4 T cells overcomes the costimulatory defect of 
fixed APCs. 
Optimal Activation  of Naive CD4 T  Cells Requires Interac- 
tion with a CTLA-4 Binding Ligand on APCs.  Costimula- 
tory signals are delivered to T cells as a result of interactions 
between CD28 receptors on T cells and B7-1 and B7-2 ligands 
on APCs (29, 32). These ligands bind to CD28 (33) and more 
efficiently to CTLA-4, a receptor expressed  on activated  T 
cells (34, 35). We have used the solubilized receptor CTLA4Ig 
to determine whether costimulation of naive CD4 T  cells 
involves a CTLA-4-reactive ligand(s) on APCs. Splenic APCs 
in the presence of the 81-104 peptide induced a high frequency 
of CD44  l~  transgenic CD4 T  cells to produce IL-2 (Table 
1, Expt. 2). In this and two additional experiments, the pres- 
ence of the CTLA4Ig fusion protein reduced the responder 
frequency an average of 4.1-fold (x/+  1.2). This effect was 
Table  1.  Role of CTLA-4-reactive  Ligands and CD28 in 
Activation of Naive CD4  T  Cells 
Expt.  APC  CTLA4Ig  c~CD28  Frequency 
Irr  No  No  4.6 (3.8-5.1) 
Fix  No  No  >20  (undetectable) 
Fix  No  Yes  2.9 (2.3-3.4) 
Irr  No  No  2.2 (1.6-2.6) 
Irr  Yes  No  6.4 (4.9-7.6) 
Irr  Yes  Yes  1.1 (0.9-1.2) 
Reciprocal responder frequencies  and 95% confidence  intervals are shown 
as determined  in the presence of 10 #M 81-104 and 2 x  104 2,000 rad 
irradiated (Irr) or paraformaldehyde-treated  (F/x) T-depleted  B10.A spleen 
cells in the absence or presence of 10 #g/ml mCTLA41g  or ~CD28 mAb 
(1:5,000 of ascites). 
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construction (36,  and data not shown). Direct ligation of 
CD28 with o~CD28 mAb overcame the inhibition seen with 
CTLA4Ig, restoring a high frequency of responding T cells. 
Thus, naive CD4 T  cells become optimally activated only 
if their costimulatory receptor(s)  engage a CTLA-4-reactive 
ligand. The failure to achieve >75% reduction in responding 
T  cells even with saturating concentrations of mCTLA4Ig 
(10/~g/ml) raises the possibility that costimulatory molecules, 
in addition to those that bind CTLA-4, may participate in 
the activation of naive  T  cells. 
Dendritic Cells and Activated B Cells as APCs for Naive CD4 
T Cells.  Because costimulation of IL-2 production by naive 
CD4 T cells depends on interactions with CTLA-4-reactive 
ligands on APCs and can be induced by CD28 ligation, one 
might predict that as long as an APC expressed  the B7-1 
or B7-2 ligands in addition to the appropriate peptide-MHC 
complex and adhesion molecules, it should be competent to 
activate naive T  cells. Splenic dendritic cells isolated by ad- 
herence express one or more CTLA-4-reactive ligands, high 
levels of MHC class II molecules, and have been reported to 
be potent APCs for primary T cell responses (1, 2, 37). Acti- 
vated B cells upregulate expression of B7-1 and B7-2, which 
confer comparable costimulatory function when transfected 
into COS cells (32).  Therefore, both these types of APCs 
would be expected to stimulate naive CD4 T cells. Dendritic 
cells have been demonstrated, however, to be 10-30-fold more 
efficient than activated B cells as APCs (1), raising the possi- 
bility that previous reports attributing stimulatory function 
to B cell blasts actually reflect  the APC function of con- 
taminating dendritic cells in the B cell preparations. There- 
fore,  to more definitively address  the question of whether 
activated B cells can stimulate naive CD4 T cells, we cocul- 
tured the cells under conditions of limiting dilution. First, 
to be certain that any detected response was due to stimula- 
tion of naive CD4 T  cells and not to potential memory T 
cell contaminants, we titrated CD44  l~  transgenic CD4 T 
cells into wells containing excess peptide and APC (Fig. 2). 
A high frequency of IL-2 producers was detected in cultures 
containing dendritic cells. As predicted, activated B cells also 
stimulated the CD4 T  cells. Similar experiments indicated 
that poly I:C-activated CBA/J (I-E k, Mls-10 B cells stimu- 
lated  comparable  frequencies  of Mls-l~-reactive  CD44 l~ 
V~6 + CD4  T  cells from nontransgenic B10.A  mice (data 
not shown). Careful quantitative analysis of 21 peptide pre- 
sentation experiments indicated that B cell blasts stimulated 
a slightly, but statistically significantly (p <0.01) lower fre- 
quency of CD4 T cells. The average responder frequency de- 
tected with dendritic cells was 1/2.79 (x/+  1.15) and with 
activated B cells was 1/4.59 (x/+  1.16). Nonetheless, this 
1.65-fold difference in frequency argues against the possibility 
that only contaminating memory T cells in the purified naive 
population were stimulated by activated B cells. 
To rigorously demonstrate that activated B cells themselves, 
and not potentially contaminating dendritic cells, were respon- 
sible for stimulating IL-2 production, we next titrated the 
APCs in cultures with excess peptide and CD44 l~  trans- 
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Figure 2.  Activated  B cells stimulate ID2 production by naive CD4 
T cells. CD44  l~  Vodl + transgenic  CD4 T cells were titrated into wells 
containing 1/zM 81-104 and either 50 dendritic cells (O) or 500 LPS- 
activated B cells (A) from BIO.A mice. The responder frequencies  were: 
1/3.1 (2.2-3.9) (O) and 1/2.1 (1.5-2.0) (&). 
genic CD4 T cells. As shown in Fig. 3 A, the frequency of 
cells in the dendritic cell population capable of inducing IL-2 
production by naive CD4 T cells was eightfold higher than 
the frequency of such APCs in the LPS-activated B cell prep- 
aration. The relative difference in APC frequency between 
these two cell types varied from 3-10-fold in several experiments, 
whether the B cells were activated  with LPS, poly I:C, or 
V~I 1 + ~-  CD4  +  Responders --~ V~6  + 
#  B10.A APC/Well  #  CBA/J  APC/Well 
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Figure 3.  Frequencies  of  dendritic  cells  and activated  B  cells  that  stimulate 
IL-2 production by naive CD4 T cells. (A) Splenic dendritic  cells (O) or 
LPS-activated  B cells (A) from  B10.A mice  were titrated into wells  con- 
taining 1 /~M 81-104 and 30 CD44  l~  Votll + transgenic CD4 T cells. 
(B) Dendritic  cells (O) or poly  I:C-activated  B cells (A) from  CBA/J  mice 
were titrated into wells containing 30 CD44  l~  Vt~6  + nontransgenic 
B10.A CD4 T cells. The APC frequencies  were: (A) 1/7.0 (5.2-8.6) (O), 
1/58 (42-73) (A); and (B) 1/300 (215-370) (O), 1/86 (56-100) (A). 
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were typically >97%  B220 +  and were  not contaminated 
with 33D1 + cells (data not shown). Therefore, the stimula- 
tory function detected in populations of activated B cells could 
not be readily attributed to contaminating non-B cells. To 
further establish  this point,  activated Mls-la-expressing B 
cells were used to stimulate IL-2 production by CD44 ]~ 
V~6 + CD4 T  cells from nontransgenic mice (Fig.  3 B). In 
this case, the expression of the TCR ligand is largely confined 
to B cells and CD8 T cells (38-40),  which probably accounts 
for the low APC frequency detected among dendritic cells. 
The observation that dendritic cells stimulated at all could 
result from contaminating activated B ceils as our dendritic 
cell preparations routinely contained 10-20%  B220 § cells. 
Thus, these results indicate that activated B cells can stimu- 
late naive CD4 T  cells to produce IL-2. 
B Cell Blasts Elicit Less IL-2 than Do Dendritic Cells.  With 
the exception of Mls-directed responses, activated B cells have 
been demonstrated to be inferior to dendritic cells in stimu- 
lating freshly isolated naive CD4 T  cells (19) and mixtures 
of naive and memory T cells (1). This inferiority could par- 
dally be explained by our finding that the subset of cells capable 
of eliciting IL-2 production by naive CD4 T cells was smaller 
in populations of activated B cells than dendritic cells. We 
showed above, however,  that the inferiority is evident even 
when the frequency of responding T  cells was examined in 
the presence  of excess presenting cells. Another possibility 
is that the potency of the cells within the stimulatory subsets 
of the two populations differed and determined the extent 
to which each T cell was stimulated. To examine this ques- 
tion, individual CD4 T cells were dispensed into wells con- 
taining excess peptide and either dendritic or activated B cells. 
The  amount of IL-2 produced by each  CD4  T  cell  was 
quantified and is presented in Fig. 4. In this experiment, the 
average amount of IL-2 produced by B cell-stimulated, re- 
sponding CD4 T  cells (0.0037  x/+  1.13 U/cell) was 4.5- 
fold less than that produced by CD4 T cells stimulated with 
dendritic cells (0.0166  x/+  1.23 U/cell). In four similar ex- 
periments, dendritic cells induced, on average, 3.70  x/+  1.13- 
fold greater IL-2 production than did activated  B cells (p 
<0.001). 
To explore whether this difference had a trivial explana- 
tion, we first considered the possibility that the B cell blasts 
did not stimulate the T cells at all, but instead produced the 
IL-2 themselves.  Freshly isolated lymph node B cells have 
been shown to express IL-2 mRNA (41). Similarly,  splenic 
B ceils stimulated in vitro secrete IL-2. Concentrations of 
FCS >2%, however, block this activity of B cells (42). Our 
cultures contained 10%  FCS.  Moreover, detection of IL-2 
in these cultures depended on the presence of a single T cell. 
Therefore, we believe that T  cells produced the IL-2 mea- 
sured in our cultures. Second, B cell stimulated in vitro ex- 
press the IL-2 receptor (43, 44). Thus, the detection of lower 
quantities of IL-2 in wells containing B blasts could be due 
to its consumption by the B cells. To test this, CTL-L growth 
in the standard IL-2 assay was examined in the presence of 
activated B cells. Although the amounts of IL-2 detected were 
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Figure  4.  Naive  CD4 T cells produce less Ib2 when stimulated  by B 
cell blasts than by dendritic calls. Individual  transgenic  CD4#  ~  V~11  + 
CD4 T cells were dispensed into wells containing  10 #M 81-104 and 103 
B10.A dendritic calls (A), 103 poly I:C-activated  B cells (B), or a mix- 
ture of 103 activated  B cells and 103 dendritic  cells (C). (Dashed bars) The 
geometric mean of the amount  of Ib2 produced  by a single T cell. Only 
positive wells (>3 SD above mean of control wells) were used in the cal- 
culation. 
diminished by higher  numbers  of B  cell blasts (104),  the 
assay was not affected by the number of activated B cells used 
in our experiments (data not shown). Finally, activated B cells 
may produce factors that are toxic either to the responding 
CD4 T  cells or the indicator CTL-L cells. To address  this 
possibility,  single CD4 T  cells were deposited in wells con- 
taining either dendritic cells or B cell blasts alone or in com- 
bination. As shown in Fig. 4 C, the amount oflL-2 detected 
in wells containing the mixture of APC (0.0218  x/+  1.21 
U/ml) was not significantly different from that detected in 
wells with dendritic cell APC alone and was significantly 
higher than in wells with B cell APC alone (see above). Thus, 
activated B cells neither consumed appreciable quantities of 
IL-2 nor interfered with the activation of naive CD4 T cells 
by dendritic cells. We therefore conclude that even within 
the stimulatory subset,  activated B cells are not as potent as 
dendritic cells in eliciting IL-2 production by naive CD4 T 
cells. 
Failure to Detect Stimulator)/Capacity  from Every APC.  The 
APC frequency detected among dendritic cell preparations 
in 27 experiments was on average 1/5.80 (x/+  1.09),  and 
similar even when the cells were.sorted for 33D1 expression 
(data not shown). A frequency of less than 1/1 might indi- 
cate that only a fraction of the cells provided both TCR oc- 
cupancy and  costimulatory signals.  Because  optimal  IL-2 
1833  Cassell  and Schwartz production required 72 h of culture, during which time there 
was extensive cell death among the APCs (data not shown), 
it is also possible that not all of the cells survived long enough 
to impart the necessary signals to the T cells. This possibility 
was explored by supplementing the cultures with trophic 
factors and determining the resultant effect on the detected 
APC frequencies. GM-CSF promotes survival of cultured mu- 
rine epidermal Langerhans cells (45). Similarly, IL-4 improves 
viability of B cells stimulated with anti-IgM (46).  Neither 
GM-CSF nor IL-4 alone had any costimulatory activity on 
freshly isolated naive CD4 T cells (data not shown). As seen 
in Fig. 5 A, m15% of the dendritic cells exhibited detectable 
APC function. Addition of IL-4 to the cultures increased this 
frequency only twofold. Supplementing the wells with GM- 
CSF, however, resulted in a 5.5-fold higher APC frequency; 
i.e., all the dendritic cells became capable  of eliciting IL-2. 
This finding has been observed in five of six experiments with 
an average increase of 2.88 (x/+  1.23)-fold in the APC fre- 
quency. In parallel experiments,  GM-CSF did not consistently 
affect APC frequencies  in activated B cell preparations (Fig. 
5 B). By contrast, in each of five trials,  the presence of IL-4 
in the cultures augmented activity of the B cells, with an 
average increase in the APC frequency of 4.33 (x/+  1.18)- 
fold. These results indicate that, depending on the condi- 
tions of culture, the calculated frequency of cells capable of 
stimulating naive CD4 T cells can be considerably underesti- 
mated.  Moreover, the extent of underestimation could be 
greater for the population of activated B cells than for den- 
dritic cells, because activated B cells exhibited poorer viability 
in culture (data not shown). Thus, it was possible that poorer 
survival of B cell blasts accounted for their inferior stimula- 
tion of IL-2 production by individual T  cells (Fig.  4).  To 
explore this possibility, the stimulatory potential of IL-4-sup- 
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Figure 5.  Lymphokines  augment  APC frequencies.  Dendritic  cells (.4) 
or poly  I:C-activated  B cells (B) from  B10.A mice  were titrated  into wells 
containing 50 CD44  zow Vot11  § transgenic  CD4 T cells and 10/zM 81- 
104 in the absence (O) or presence of 10 ng/ml rmGM-CSF (A) or 50 
U/ml rlL-4 ([]). APC frequencies  were: (.4) 1/6.6 (5.0-7.8) (O), 1/1.2 
(0.9-1.5) (A), 1/3.6 (2.7-4.3) (I-7); and (B) 1/122.5 (91.7-147.8) (O), 
1/152 (115-182) (A), 1/16.8 (14.4-18.3) (Vq). 
plemented B cell blasts was assessed by measuring the amount 
of IL-2 they elicited from individual naive CD4 T cells. As 
seen in Fig.  6, IL-4 did not affect the maximum amount of 
IL-2 elicited by activated B Cells. In this experiment, the mean 
amount of IL-2 induced by activated B cells was 0.00052  x/+ 
1.16 U/cell in the absence of IL-4 (Fig. 6 B) and 0.00038  x/+ 
1.11 U/cell in its presence (Fig. 6 D). Thus, independent of 
their apparently lower APC frequency due to poor survival 
in culture, activated B cells failed to elicit as much IL-2 from 
naive CD4 T  cells as did dendritic cells (0.0011  x/+  1.19 
U/cell, Fig.  6 A). 
Nature of the Deficiency  of  Activated B Cells As APC.  We 
next  wished  to  determine  the  basis  for  the  stimulator), 
deficiency of activated B cells. According to the two signal 
models of IL-2 induction in CD4 T cells, the lower potency 
of activated B cells could reflect deficiencies either in costimu- 
lation or antigen presentation. We compared the expression 
of potentially costimulatory CTLA-4-reactive molecules on 
dendritic cells and activated B cells. The histograms shown 
in Fig. 7 A  demonstrate that both dendritic cells and acti- 
vated B cells expressed high levels of CTLA-4-reactive ligands, 
although there was consistently threefold less on B cells than 
on dendritic cells. The functional role of these ligands was 
assessed by determining the frequencies of CD4 T cells stimu- 
lated by either type of APC in the absence or presence  of 
CTLA4Ig (Fig. 7, B and C). The frequency of CD4 T cells 
induced to secrete IL-2 in the presence of CTLA4Ig dropped 
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Figure 6.  CD28 ligation  overcomes  deficient  APC function  of B cell 
blasts. Individual  CD44  low Vall+ CD4 cells were dispensed into wells 
containing 10/zM 81-104 and 103 B10.A dendritic  cells (A) or 5 x  103 
poly I:C-activated  B cells in the absence (B) or presence of c~CD28 mAb 
(C) or 50 U/ml IL-4 (D). Data are presented as in Fig. 4. 
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Figure 7.  Role  for CTLA-4-binding  ligands 
in APC function  of dendritic  cells  and activated 
B cells. (.4) Dendritic  cells (  , -.-) or poly 
I:C-activated  B cells (- - -, ....  ) were  incubated 
with 2.4G2, followed  by hCTLA4Ig (  , 
-- -) or buffer (-.; ....  ). All samples were fur- 
ther  incubated with  biotinylated mouse 
anti-human Ig,  then PE-conjugated strep- 
tavidin. For the LDA, CD44  low Vc~11  + trans- 
genic CD4 T cells  were titrated  into  wells  con- 
taining 81-104 and either  30 dendritic  cells (B) 
or 200 poly I:C-activated  B cells (C) from 
B10.A mice. Cells were cultured in medium 
alone (O), or were supplemented with 10 
gg/ml CTLA4Ig  (&) or both CTLA4Ig  and 
cxCD28 ([]). The responder  frequencies  were: 
(B) 1/3.4 (2.6-3.9) (O), 1/10.8 (7.6-13.7) (A); 
and (C) 1/4.3 (3.3-5.2) (O), 1/35.1 (24.9--44.5) 
(&), and 1/3.3 (2.6-3.8) ([]). 
in three experiments by an average of 3.07-fold (x/+  1.43) 
when stimulated by dendritic cells and 11.45-fold (x/+  1.14) 
in four experiments when stimulated by activated B cells. 
L6Ig, a control reagent, did not affect stimulation by either 
APC type (data not shown). Addition of oLCD28 mAb com- 
pletely overcame the CTLA4Ig-mediated inhibition of stim- 
ulation by B  cell  blasts  (Fig.  7  C),  suggesting  that  the 
CTLA4Ig effect was not nonspecific. Therefore, maximal APC 
function of both types of cells involves ligands with affinity 
for CTLA-4. In addition to the quantitative differences in 
expression of CTLA-4-reactive ligands, it is possible that the 
two APC populations differed qualitatively as well. The greater 
blocking effect of CTLA4Ig on B cell blasts than on den- 
dritic cells  suggests that dendritic cells possess  alternative 
costimulatory ligands. Incomplete CTLA4Ig-mediated block- 
ing of dendritic cell-stimulated primary alloresponses  was 
similarly observed by Lenshow et al.  (47).  Therefore, it is 
possible  that  activated B  cells  are  relatively inefficient at 
stimulating IL-2 production because  they do not express 
sufficient levels of all the costimulatory molecules necessary 
for optimal activation of naive CD4 T  cells. 
To test this possibility, the ability of activated B cells to 
stimulate naive CD4 T cells was determined in the presence 
or absence  of aCD28  mAb  (Table 2).  In the presence  of 
c~CD28, activated B cells exhibited a much higher APC fre- 
quency for peptide presentation than in the absence of the 
mAb.  An  augmented APC  frequency in  the  presence  of 
c~CD28 mAb was also detected for activated B cells presenting 
Mls-l'  to  VB6 +  CD4  T  cells  (data  not  shown).  These 
findings indicate that the low frequency of APC within a 
population of activated B cells is due in part to a low fre- 
quency of cells with sufficient costimulatory function to ac- 
tivate naive CD4 T  cells. 
We also examined the amount of IL-2 produced by in- 
dividual CD4 T  cells stimulated by activated B cells in the 
absence or presence of olCD28 mAb. The addition of o~CD28 
mAb to the cultures containing B cells resulted in the produc- 
tion of larger quantities of IL-2 (mean =  0.0012  x/+  1.12 
U/cell, Fig. 6 C compared with 0.00052  x/+  1.16 U/cell, 
Fig. 6 B), as high as those obtained in wells containing den- 
dritic cells (mean =  0.0011 x/+  1.19 U/ml, Fig. 6 A). This 
is one of seven similar experiments. Thus, the subset of acti- 
vated B cells that can stimulate CD4 T  cells does so less 
efficiently than dendritic cells, at least in part because  of a 
deficiency in costimulation. 
We next asked whether, in addition to being deficient in 
their ability to costimulate, activated B cells also provided 
suboptimal stimulation through the TCR. The expression 
of adhesion molecules is critical for optimal TCR-mediated 
activation (48, 49). Resting B cells express low levels of these 
molecules and have been characterized as having minimal APC 
function for unprimed T  cells (37).  In contrast, both den- 
dritic cells and activated B cell express higher levels of adhe- 
sion molecules such as LFA-1 and ICAM-1,  although the 
levels on activated B cells in our experiments were consis- 
tently two- to threefold lower than on dendritic cells (Fig. 
8, B and C). Expression of I-E  k, the presenting element for 
the 81-104 peptide, was roughly equivalent on both cell types 
as shown in Fig. 8 A, and higher than the low levels reported 
on resting B cells (1). To examine the relative ability to en- 
gage the TCR, we compared the APC frequencies  of den- 
dritic cells and activated B cells at decreasing concentrations 
of the 81-104 peptide, aCD28 was included in the wells with 
B cells to ensure that costimulation was not limiting in these 
cultures. The results shown in Table 2 indicate that peptide 
became limiting for optimal antigen presentation at a three- 
fold lower concentration for dendritic cells than for activated 
B cells in one experiment, and at the same concentration in 
a second experiment. By contrast, the ability of resting B 
cells to stimulate CD4 T cells was always more sensitive to 
decreases  in  peptide concentration (Table  2  and data not 
shown). We interpret these data to indicate that activated 
B cells are slightly deficient in expressing the required com- 
bination of adhesion molecules and peptide-MHC complexes 
to  sufficiently engage  the  TCR  and initiate the  signal  1 
pathway. 
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Figure 8.  Relative expression 
of adhesion molecules. Dendritic 
cells (  ) and poly I:C-acti- 
vated B cells (- - -) were incubated 
with 2.4G2  followed by FITC- 
conjugated  antibodies  to  I-E, 
LFA-1, and ICAM-I. 
Discussion 
Our understanding of the roles played by various APC in 
stimulating T  cell immunity remains incomplete. Cells of 
the Langerhans/dendritic cell lineage take up, process,  and 
present soluble protein (50-53) and have been implicated in 
the initial capture of antigen and presentation of antigen- 
derived peptides (54). Moreover, because dendritic cells stimu- 
late freshly explanted T  cells from unmanipulated animals 
more efficiently than do B cells or macrophages (1, 55),  the 
idea that dendritic cells are the initiating APC in immune 
responses has gained acceptance (15,  17). 
There are conflicting reports concerning the ability of ac- 
tivated B cells to stimulate unprimed T cells. In support of 
such a role, optimal T  cell priming was found to require B 
cells. Thus, lymph node T  cells from B cell-depleted mice 
injected with protein antigen in CFA proliferated poorly when 
challenged with antigen in vitro (12-16).  T cell priming did 
occur, however, when haptenated antigen in CFA was ad- 
ministered together with hapten-primed B cells (15). Lin et 
al. (17) have proposed a model in which dendritic cells prime 
the first cohort of native T  cells, which then provide help 
for activation orB cells. Once activated, the B cells can then 
directly prime additional naive T  cells (16,  17). In this re- 
port, however, it was not shown that activated B cells directly 
stimulated naive T  cells. Instead, the activated B cells may 
have produced antibody that formed complexes with the an- 
tigen, and the initiating APC may have been a non-B cell 
capable of taking up the complexes and presenting antigenic 
fragments (10). 
There are two recent reports that contradict the notion 
that activated B cells stimulate naive T cells. In the first case, 
Fuchs and Matzinger (22) demonstrated that injection into 
naive mice of activated B cells, unlike unfractionated spleen 
cells, failed to prime and instead tolerized CD8 CTL precursors 
(CTLp) specific for the H-Y antigen expressed by the injected 
cells. In the second study, Ronchese and Hansmann (21) trans- 
ferred HSA  ]~  thymocytes into SCID mice either alone or 
with antigen-primed B cells. Injection of antigen into both 
sets of reconstituted recipients primed only those T cells re- 
stricted to the MHC of the non-B APC. The authors inter- 
preted these results to mean that activated B cells could not 
stimulate naive T  cells (21). 
Given the controversy with in vivo experiments and the 
failure of in vitro studies to demonstrate beyond doubt that 
activated B cells, rather than non-B contaminants, stimulate 
naive T  cells, we decided to reexamine this question. As a 
convenient source of naive T cells, we used CD4 [~  Vc~11  + 
cells from TCR transgenic mice. To assure ourselves that the 
Table  2.  Relative  Ed~ciency of Peptide Presentation by Different APCs 
Expt.  (81-104)  PIC B*  PIC B  plus aCD28  Dendritic cells  Dense B  cells 
1  1.0  47.4  (39.6-52.7)  9.3  (8.2-10.0)  6.8  (5.3-8.0) 
0.1  10.5  (8.9-11.6)  16.8  (13.1-19.6) 
0.01  31.0  (23.8-36.7)  27.8 (21.7-32.3) 
2  10.0  122  (92-148)  4.4  (3.3-5.3) 
1.0  8.0 (6.1-9.5)  5.6 (4.1-6.7) 
0.33  8.5  (6.7-9.8)  5.6 (4.4-6.5) 
0.11  13.5 (10.1-16.3)  9.1 (6.9-10.8) 
0.037  25.8 (19.1-31.3)  11.7 (8.7-14.2) 
0.012  66.7 (49.4-81.3)  25.9 (19.2-31.4) 
6.5 (5.2-7.5) 
10.5 (7.9-12.6) 
14.5 (11.1-7.2) 
74.1 (55.4-9.5) 
378 (254-505) 
Reciprocal APC frequencies and 95% confidence intervals are shown as determined in the presence of CD44  ]~  transgenic CD4 T cells, the absence 
or presence of o~CD28 mAb, and the indicated micromolar  concentrations  of peptide 81-104. 
* Poly l:C-activated B cells. 
1836  Activated B Cells Are Deficient in Costimulation activation requirements of these cells reflected those of naive 
cells developing in a normal animal, we included in our study 
Mls-reactive CD44 l~  VB6 +  CD4  T  cells  isolated  from 
nontransgenic mice. IL-2 production by these naive CD4 T 
cells required costimulatory signals  that could be provided 
by CD28  ligation  and that depended on interaction with 
CTLA-4-reactive ligands expressed by APC. Since both den- 
dritic cells and B cell blasts express  such ligands and since 
both B7-1  and B7-2 have costimulatory function (35,  56), 
both APC types were expected to stimulate naive CD4 T 
cells. Indeed, we found that the frequency of naive CD4 T 
cells capable of responding either to 81-104/E k or to Mls 
presented by activated B cells was high,  although slightly 
lower than the frequency of naive T cells responding to 81- 
104/E  k presented by dendritic cells.  This was not evident 
from previous studies.  Using primary MLR against alloan- 
tigens other than Mls, Metlay et al. (1) reported that 10-30 
times higher numbers of B cell blasts were required to stimulate 
responses equivalent to those induced by dendritic cells. Our 
results in nonlymphokine-supplemented medium, where the 
APC survival is poor, confirm this finding. Metlay et al. (37) 
noted that the reduced potency of activated B cells could mean 
that B cell blasts are efficient APC only for a subset of T 
cells or that B cell blasts stimulate all T cells but only 3-10% 
as well as dendritic cells.  A  third possibility is that only a 
small subset of activated B cells has detectable APC func- 
tion. Our results strongly support the second and third pos- 
sibilities, and are compatible with a small contribution from 
the first. In addition, the frequency of B cells capable of eliciting 
IL-2 production by naive transgenic CD4 T  cells was high 
enough, especially when cultured with IL-4, to rule out the 
possibility that the observed stimulating capacity was due 
to contaminating dendritic cells or any other non-B cell. De- 
tection of a higher frequency of Mls-presenting APC among 
activated B cells than among dendritic cells provides particu- 
larly compelling evidence that B cells can stimulate naive CD4 
T  cells. 
Because  of poor  cell survival in  vitro,  the  stimulatory 
deficiency of activated B cells may not have been reliably in- 
dicated by the responder and APC frequencies we detected 
in the cultures. The single cell experiments, however, revealed 
that the extent to which T  cells were activated to produce 
IL-2 was fourfold lower after stimulation with B cell blasts 
than with dendritic cells. Metlay et al.  (37) hold the view 
that the relative inability of B cell blasts to form aggregates 
with T  cells accounts for the inferior stimulatory function 
of activated B cells. These investigators have documented a 
role for LFA-1 in the antigen-dependent interaction between 
T cells and both APC types (55), and suggest that dendritic 
cells, but not B blasts, have additional clustering capabilities 
that are independent of LFA-1 and antigen (37).  We found 
that B cell blasts expressed slightly lower levels of LFA-1 and 
ICAM-1 and that their APC function was, in some cases, 
more sensitive to decreases in peptide concentration than was 
seen with dendritic cells. Although our data as well as that 
of  Jenkins et al. (57) indicate that potential differences in LFA- 
1-dependent T-APC interactions do not always exert a de- 
tectable effect on TCR occupancy for either naive or memory 
T  cells, it is possible that the superior clustering function 
of dendritic cells serves to facilitate delivery of costimulatory 
signals. Consistent with this, we found with nonlimiting pep- 
tide concentrations that the relative stimulatory deficiency 
of the B cells was overcome by directly ligating the CD28 
molecule on the CD4 T cell. Thus, activated B cells are also 
poorer APC because they fail to provide adequate costimula- 
tory signals to naive CD4 T cells. This costimulatory deficiency 
of activated B cells has recently been observed for stimula- 
tion of certain Thl clones as well (58). 
Our studies show that naive peripheral CD4 T cells stimu- 
lated by B cell blasts produce only 25% the amount of IL-2 
elicited by dendritic cells.  This observation might help to 
reconcile some of the conflicting reports in the literature. In 
the experiments of Lin et al.  (17),  where activated B cells 
are thought to play a role in T cell priming, the antigen was 
administered in CFA. This may have eliminated the costimu- 
lation deficiency of the primed B cells and allowed them to 
present antigen to naive T cells. In the SCID reconstitution 
experiments of Ronchese and Hausmann (21), it was noted 
that T  cells restricted to the MHC of cotransferred B cells 
were primed when splenic rather than thymic CD4 T cells 
were transferred into the mice. The authors believe this was 
due to contaminating antigen-experienced  T cells in the trans- 
ferred splenic populations. Another possibility,  however, is 
that the inferiority of activated B cells may be more pronounced 
with thymocytes than it is with naive peripheral T cells. In 
the study of Fuchs and Matzinger, (22) H-Y specific CTLp 
were tolerized after recognition of antigen on activated B cells. 
CTL priming often requires activation ofCD4 T cells to pro- 
duce IL-2 and perhaps other factors as well (59-62), in the 
absence of which the CTL become tolerized (63, 64). In pre- 
liminary experiments, the frequency of IL-2 producers de- 
tected in H-Y tolerant animals was higher than that seen in 
unprimed mice, but two- to threefold lower than that seen 
in primed animals (Schwartz, R. H. and C. Chen, unpub- 
lished observations). This suggests that the CD4 population 
was affected. It is not known how much IL-2 a CD4 T cell 
must produce either to support its own clonal expansion or 
to provide help in the activation of other T  cells. Whether 
a fourfold reduction in lymphokine production is large enough 
to account for the CTL tolerance or lack of thymocyte priming 
reported in vivo is unclear. A  three- to fourfold difference 
in production in vivo of other Thl lymphokines, however, 
is associated  with a dramatic physiologic difference in sus- 
ceptibility to certain bacterial infections (65). 
The major finding of the current study is that, in spite 
of their high levels of CTLA-4/CD28-reactive ligands, acti- 
vated B cells are quantitatively deficient in providing costimula- 
tory signals necessary for IL-2 production by naive CD4 T 
cells. To some extent, the costimulatory ligands involved in 
the APC function of both dendritic cells and activated B cells 
appear to be similar since CTLA4Ig impaired stimulation 
of T  cells in response to either APC. The relative roles of 
the currently known murine CTLA-4 ligands, B7-1 and B7-2, 
on the two APC types is not entirely clear. B7-1  has been 
1837  Cassell  and Schwartz reported to represent the major costimulatory ligand on some 
but not all APC capable of delivering such signals (57, 66). 
Activated B cells express relatively low levels orB7-1 and (xB7-1 
mAb does not effectively  block their APC function (35), im- 
plying that B7-1  plays a minor role in the stimulatory ac- 
tivity of B cell blasts. Murine splenic dendritic cells and cul- 
tured Langerhans cells have been shown to transcribe and 
express B7-1  (48,  67).  olB7-1 mAb also fails to fully block 
stimulation of human T cells by allogeneic dendritic cells (66). 
In contrast to B7-1, B7-2 is highly expressed by B cell blasts 
and represents  the primary CTLAo4-reactive ligand on these 
cells (35). Moreover, B7-2 appears to be the major costimula- 
tory molecule on activated B cells because c~B7-2 mAb blocks 
their APC function (35).  It is interesting to note that we 
have found, in preliminary experiments, that whereas cxB7-2 
mAb readily blocks IL-2 production by naive CD4 T  cells 
induced by activated B cells, it has no effect on the response 
elicited by dendritic cells (our unpublished observations). Be- 
cause dendritic cell-induced IL-2 production is incompletely 
blocked by CTLA4Ig, cxB7-1, and c~B7-2 mAb, there may 
be as yet undefined costimulatory ligands important to the 
unique function of these cells. 
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